Infectious Diseases (except HIV/AIDS)

  1. Development and validation of an in-house, low-cost SARS-CoV-2 detection assay

    1. Fatimah S. Alhamlan
    2. Ahmed A. Al-Qahtani
    3. Dana M. Bakheet
    4. Marie F. Bohol
    5. Sahar I. Althawadi
    6. Maysoon S. Mutabagani
    7. Reem S. Almaghrabi
    8. Dalia A. Obeid

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. A Prediction Model to Prioritize Individuals for a SARS-CoV-2 Test Built from National Symptom Surveys

    1. Saar Shoer
    2. Tal Karady
    3. Ayya Keshet
    4. Smadar Shilo
    5. Hagai Rossman
    6. Amir Gavrieli
    7. Tomer Meir
    8. Amit Lavon
    9. Dmitry Kolobkov
    10. Iris Kalka
    11. Anastasia Godneva
    12. Ori Cohen
    13. Adam Kariv
    14. Ori Hoch
    15. Mushon Zer-Aviv
    16. Noam Castel
    17. Carole Sudre
    18. Anat Ekka Zohar
    19. Angela Irony
    20. Tim Spector
    21. Benjamin Geiger
    22. Dorit Hizi
    23. Varda Shalev
    24. Ran Balicer
    25. Eran Segal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Preliminary evaluation of COVID-19 disease outcomes, test capacities and management approaches among African countries

    1. Adebayo A. Otitoloju
    2. Esther O. Oluwole
    3. Kafilat A. Bawa-Allah
    4. Mayowa J. Fasona
    5. Ifeoma P. Okafor
    6. Chukwuemeka Isanbor
    7. Vincent O. Osunkalu
    8. Abimbola A. Sowemimo
    9. Adegoke O. Keshinro
    10. Idowu A. Aneyo
    11. Olawale S. Folarin
    12. Akinbami O. Oladokun
    13. Oluwatosin J. Akinsola
    14. Christianah I. Ayolabi
    15. Tenny O. Egwuatu
    16. Victor A. Owoyomi
    17. Anthony E. Ogbeibu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Early assessment of knowledge, attitudes, anxiety and behavioral adaptations of Connecticut residents to COVID-19

    1. Toan Ha
    2. Stephen Schensul
    3. Judy Lewis
    4. Stacey Brown

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Modeling the Effects of Nonpharmaceutical Interventions on COVID-19 Spread in Kenya

    1. Duncan K. Gathungu
    2. Viona N. Ojiambo
    3. Mark E. M. Kimathi
    4. Samuel M. Mwalili

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials

    1. Juan A. Siordia
    2. Michael Bernaba
    3. Kenji Yoshino
    4. Abid Ulhaque
    5. Sooraj Kumar
    6. Mario Bernaba
    7. Edward Bergin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. COVID-19; Systematic and literature review of transmission, case definitions, clinical management and clinical trials.

    1. Laura McArthur
    2. DhanaSekaran Sakthivel
    3. Ricardo Ataide
    4. Felicia Chan
    5. Jack S Richards
    6. Charles A Narh

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Ostavimir is ineffective against COVID-19: in silico assessment, in vitro and retrospective study

    1. Qi Tan
    2. Yang Jin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Changing trends of excess self-protective behavior, and association with belief in prevention myths during the COVID-19 epidemic in China: A panel study

    1. Xiaozhao Yousef Yang
    2. Sihui peng
    3. Tingzhong Yang
    4. Ian R.H. Rockett

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Hyperpyrexia leading to death in a patient with severe COVID-19 disease

    1. Tanu Singhal
    2. Sourabh Phadtare
    3. Sunil Pai
    4. Amit Raodeo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 72 of 716 Next